1.
Kotlyarchuk K, Maslyak Z, Lukianova A, Tsyapka O, Selina I, Usenko A. Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Med. perspekt. [Internet]. 2015Sep.23 [cited 2024Dec.14];20(3):67-73. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/53687